# Antisense therapy targeting apolipoprotein(a): a randomised, double-blind, placebo-controlled phase 1 study

Article · Sotirios Tsimikas, Nicholas J. Viney, Steven G. Hughes, Walter Singleton, Mark J. Graham, Brenda F. Baker, Jennifer Burkey, Qingqing Yang, Santica M. Marcovina, Richard S. Geary, Rosanne M. Crooke, Joseph Lee Witztum

- Archive id: doi:10.1016/s0140-6736(15)61252-1
- Published: 2015-07-22
- Venue: The Lancet
- DOI: https://doi.org/10.1016/s0140-6736(15)61252-1
- PMID: 26210642
- Citations: 460
- Source URL: https://doi.org/10.1016/s0140-6736(15)61252-1
- Provenance: openalex

_Abstract not reproduced: its license does not permit redistribution. See the source URL._

Topics: [Cardiovascular Therapeutics](https://space-kitty.com/topics/cardiovascular-innovation)

---
Space Kitty Archive · https://space-kitty.com · API: https://space-kitty.com/api/v1 · MCP: https://space-kitty.com/mcp · Premium: $0.20/request via x402 (Base Sepolia (testnet)). Metadata: arXiv (CC0), OpenAlex (CC0), Europe PMC (CC BY/CC0 works), ClinicalTrials.gov.